New Platform Allows Isolation of Rare Cells from Low Count Suspensions

The new DEPArray™ Platform System from Silicon Biosystems SpA offers the unique possibility of controlling individual cell and micro-particle motion inside a micro-chamber after multiparametric, image-based identification. A key benefit is the isolation of rare cells from low count suspensions that is contaminant free with single-cell resolution. This enables unbiased molecular analysis or culturing.

This new DEPArray™ Platform system will be launched at the Targeted Cancer Meeting in Zurich on September 21, 2010.